# CCR5-blockade in Metastatic Colorectal Cancer

> **NCT01736813** · — · COMPLETED · sponsor: **National Center for Tumor Diseases, Heidelberg** · enrollment: 12 (actual)

## Conditions studied

- Colorectal Cancer
- Neoplasm Metastasis
- Liver Metastases

## Interventions

- **DRUG:** Maraviroc

## Key facts

- **NCT ID:** NCT01736813
- **Lead sponsor:** National Center for Tumor Diseases, Heidelberg
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-12
- **Final completion:** 2014-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736813, "CCR5-blockade in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01736813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*